Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MacroGenics
company
About
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
- 501 - 1000
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $9.80M
- Industries
- Biotechnology,Health Care,Manufacturing
- Founded date
- Jan 1, 2000
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases.The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology.The company was founded in 2000 and is headquartered in Rockville, Maryland.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$135.40M
MacroGenics has raised a total of
$135.40M
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2010 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2010 | Grant | $9.80M | 1 |
National Institutes of Health
|
— | Detail |
| Oct 23, 2008 | Series D | $25M | 3 | — | — | Detail |
| Jul 29, 2008 | Series D | $12.50M | 1 | — | — | Detail |
| May 17, 2006 | Series C | $45M | 1 | — | — | Detail |
| Oct 15, 2004 | Series B | $30.50M | 3 |
TPG
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
6
MacroGenics is funded by 6 investors.
National Institutes of Health
and TPG
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
TPG
|
— | Series D |
CIDC Consultants
|
— | Series D |
|
|
— | Series D |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
